Skip to main content
Premium Trial:

Request an Annual Quote

BioExpress Inflammation Suite, EMBL Nucleotide Sequence Database, QuickGO, BASE, GenomePixelizer, DiagHunter, Merlin, Pedro


Gene Logic has launched the BioExpress Inflammation Suite, expression content related to inflammatory and autoimmune diseases. The suite contains three components: human tissue samples and associated clinical annotations; animal disease models; and in vitro cellular model systems.


Release 74 of the EMBL Nucleotide Sequence Database is available from (UK), (US), and other mirror sites. Release 74 is about 15.9 GB compressed and 103 GB uncompressed and contains 23,234,788 sequences comprising 30,356,786,718 nucleotides, an increase of about 8.8 percent over release 73 in December.


An updated version of QuickGO, the European Bioinformatics Institute’s web-based browser for Gene Ontology data, is available at The new version offers updated search and display interfaces.


Version 1.2.0 of the open source web-based gene expression database server BASE is available from the Theoretical Physics and Oncology groups at Lund University, at The new release includes support for non-two-channel data, installation-specific reporter and raw data columns, and GAL files.


New versions of the GenomePixelizer 2D plotter and DiagHunter synteny identification software are available from the University of California, Davis, at and, respectively.


The Center for Statistical Genetics at the University of Michigan has released version 0.9.9 of Merlin, a pedigree analysis software package, at Enhancements include improved PDF output and tracking of user-specified allele frequencies.


The University of Manchester has released Pedro, a data modeling tool designed for sharing proteomics data in XML, at

Filed under

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.